These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 23754607

  • 1. Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.
    Dassler K, Scholle FD, Schütz G.
    Magn Reson Med; 2014 May; 71(5):1826-33. PubMed ID: 23754607
    [Abstract] [Full Text] [Related]

  • 2. Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study.
    Cyran CC, Paprottka PM, Schwarz B, Sourbron S, Ingrisch M, von Einem J, Pietsch H, Dietrich O, Hinkel R, Bruns CJ, Reiser MF, Wintersperger BJ, Nikolaou K.
    AJR Am J Roentgenol; 2012 Feb; 198(2):384-91. PubMed ID: 22268182
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC, Fu Y, Rogut V, Chaopathomkul B, Wendland MF, Shames DM, Brasch RC.
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG.
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
    Zhu W, Kato Y, Artemov D.
    MAGMA; 2014 Apr; 27(2):161-70. PubMed ID: 23807596
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.
    Lamuraglia M, Barrois G, Le Guillou-Buffello D, Santin M, Kerbol A, Comperat E, Coron A, Lucidarme O, Bridal SL.
    Technol Cancer Res Treat; 2020 Apr; 19():1533033819886896. PubMed ID: 32065066
    [Abstract] [Full Text] [Related]

  • 13. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results.
    Loo CE, Teertstra HJ, Rodenhuis S, van de Vijver MJ, Hannemann J, Muller SH, Peeters MJ, Gilhuijs KG.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1331-8. PubMed ID: 18941065
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced ultrasound with perflubutane in the assessment of anti-angiogenic effects: early prediction of the anticancer activity of bevacizumab in a mouse xenografted model.
    Watanabe R, Munemasa T, Matsumura M.
    Ultrasound Med Biol; 2015 Sep; 41(9):2497-505. PubMed ID: 26022792
    [Abstract] [Full Text] [Related]

  • 15. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR, Jost G, Pietsch H, Weibrecht M, Perkuhn M, Boschewitz JM, Keil VC, Träber F, Kukuk GM, Schild HH, Willinek WA.
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T, Vollnberg B, Schwenke C, Kilic E, Huppertz A, Taupitz M, Franiel T.
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [Abstract] [Full Text] [Related]

  • 19. Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial.
    Breuer J, Gutierrez J, Latchaw R, Lehr R, Sorensen AG.
    J Magn Reson Imaging; 2014 Feb; 39(2):410-8. PubMed ID: 23681501
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.